The past week has seen a number of medical device company acquisitions, among them Boston Scientific’s acquisition of Rhythmia Medical, a developer of mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter. Meanwhile, Forbes worries that the Affordable Care Act, including the medical device excise tax, will harm medical device innovation.

• Boston Scientific to Acquire Rhythmia Medical (Qmed)
• Medical Device Tax Update from Advamed, Plus User Fees Under Threat (MD+DI)
• EC’s Proposed Scrutiny Procedure Will Not Improve Patient Safety but Could Harm Industry, Says Eucomed Chief Executive (medtechinsider)
• Hip Resurfacing Unsuitable for Women, Study Finds (Qmed)
• Analysis: When Implanted Medical Devices Go Wrong, Who Pays? (Reuters)
• Study Finds Approval Time for Medical Devices Often Lags (DOTmed News)
• Obamacare Will Stifle Healthcare Innovation, Making It a Real Pain (Forbes)